Cargando…
Efficacy and safety of selective decontamination of the digestive tract (SDD) to prevent recurrent hepatic cyst infections in polycystic liver disease: a retrospective case series
BACKGROUND: Hepatic cyst infection is a complication of polycystic liver disease (PLD) that causes substantial morbidity. Repetitive infection is frequent and is increasingly difficult to treat. As translocated gut bacteria are considered the cause, we hypothesize that selective decontamination of t...
Autores principales: | Bernts, Lucas H P, Dekker, Shosha E I, Soonawala, Darius, Brüggemann, Roger J M, Wertheim, Heiman F L, de Fijter, Johan W, Drenth, Joost P H, Lantinga, Marten A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443730/ https://www.ncbi.nlm.nih.gov/pubmed/32437580 http://dx.doi.org/10.1093/jac/dkaa186 |
Ejemplares similares
-
Selective decontamination of the digestive tract (SDD) in critically ill patients: a narrative review
por: Wittekamp, Bastiaan H. J., et al.
Publicado: (2019) -
Urinary metabolites associate with the rate of kidney function decline in patients with autosomal dominant polycystic kidney disease
por: Dekker, Shosha E. I., et al.
Publicado: (2020) -
Carriage of antibiotic-resistant Gram-negative bacteria after discontinuation of selective decontamination of the digestive tract (SDD) or selective oropharyngeal decontamination (SOD)
por: de Jonge, E., et al.
Publicado: (2018) -
Hepatic Cyst Infection During Use of the Somatostatin Analog Lanreotide in Autosomal Dominant Polycystic Kidney Disease: An Interim Analysis of the Randomized Open-Label Multicenter DIPAK-1 Study
por: Lantinga, Marten A., et al.
Publicado: (2016) -
Management of portal hypertension and ascites in polycystic liver disease
por: Bernts, Lucas H. P., et al.
Publicado: (2019)